R2

Brain Cancer Finally Gets the PET Scan It Has Been Missing

Obesity treatment is becoming a portfolio, not a product. Lilly’s EASD lineup shows what comes next

Medical AI can ace the benchmark and still fail the clinic. Real-world evidence is the next test

The Recall Is Still In The Freezer.

AI is moving inside the medical record. Privacy is only part of the risk

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.

Outbreaks Ignore Borders.

Cardiovascular AI is getting better. That does not mean it is getting fairer

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
